deaths (OS)

mML - L2 - all population metastatic/adv melanoma (mML) mML - 2nd line (L2) mML - L2 - all population

versus Standard of Care (SoC)
pembrolizumab (2mg/kg) vs. Standard of Care (SoC) 1 -318 [-1266; 631] /10000
123/180 vs. 128/179